Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Crowd-Sourced Benchmarking of Single-Sample Tumor Subclonal Reconstruction, Adriana Salcedo, Maxime Tarabichi, Alex Buchanan, et al.
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients., Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Long-Term Follow-Up and Combined Phase 2 Results of Eprenetapopt and Azacitidine in Patients With TP53 Mutant MDS/AML, David A Sallman, Rami S Komrokji, Amy E Dezern, et al.
Tnik-Driven Regulation of ERK5 Transcriptional Activity in Endothelial Cells, Venkata Subrahmanya Kumar Samanthapudi, Sivareddy Kotla, and Nhat-Tu Le
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes, Fnu Sameeta, Wei Wang, Fatima Zahra Jelloul, et al.
Advancing the Development of TRIP13 Inhibitors: A High-Throughput Screening Approach, Rae M Sammons, Soma Ghosh, Lacin Yapindi, et al.
Rapid Whole Genome Sequencing Uncovers a Triple Diagnosis: X-Linked Chondrodysplasia Punctata, MECP2-Related Disorder, and Mosaic Jacobs Syndrome, Megan Samuels, Kathleen Shields, Paul Hillman, et al.
Status of Abortion Curriculum in Genetic Counseling: Survey of Graduate Programs and Recent Graduates in the United States, Gina Sanchez, S Shahrukh Hashmi, Erica Bednar, et al.
PKA-Driven SPP1 Activation as a Novel Mechanism Connecting the Bone Microenvironment to Prostate Cancer Progression, Pablo Sanchis, Agustina Sabater, Julia Lechuga, et al.
Association of Genetic Scores Related to Insulin Resistance With Neurological Outcomes in Ancestrally Diverse Cohorts From the Trans-Omics for Precision Medicine (TOPMed) Program, Chloé Sarnowski, Yixin Zhang, Farah Ammous, et al.
Predicting Chemotherapy Responsiveness in Gastric Cancer Through Machine Learning Analysis of Genome, Immune, and Neutrophil Signatures, Shota Sasagawa, Yoshitaka Honma, Xinxin Peng, et al.
Interactive 3D Segmentation for Primary Gross Tumor Volume in Oropharyngeal Cancer, Mikko Saukkoriipi, Jaakko Sahlsten, Joel Jaskari, et al.
From Imaging to Impact: A Multi-Disciplinary T32 Program Framework and Initial Insights for Training in Image-Guided Cancer Therapy, Kari J Brewer Savannah, Stephen Y Lai, Clifton D Fuller, et al.
Sustained Growth-Promoting Effects of Vosoritide in Children With Achondroplasia From an Ongoing Phase 3 Extension Study, Ravi Savarirayan, Melita Irving, William R Wilcox, et al.
Non-invasive Tools for Analysis of Plasma Membrane Protein Topology in Living Cells, Daria Savenkova, Leysan Bulatova, Vera Skripova, et al.
Isolation and Functional Properties of Highly-Purified N-terminal Domain of Human NaPi2b by Scalable “Resin Overload” Technique, Daria Savenkova, Irina Makarenko, Daria Nedorezova, et al.
Efficacy and Safety of Oral Decitabine/Cedazuridine in the Chronic Myelomonocytic Leukaemia Subpopulations From Phase 2 and 3 Studies, Michael R Savona, Olatoyosi Odenike, Gail J Roboz, et al.
Its Own Architect: Flipping Cardiolipin Synthase, Katsuhiro Sawasato, William Dowhan, and Mikhail Bogdanov
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism, Kapil Saxena, Shao-Hsi Hung, Esther Ryu, et al.
The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem, Aislyn Schalck, Tuan Tran, Jianzhuo Li, et al.
Human Cerebral Organoids Model Tumor Initiation and Infiltration in an Autologous Astrocyte-Supported Setting, Esther Schickel, Tamara Bender, Leon Kaysan, et al.
Further Delineation of the SCAF4-Associated Neurodevelopmental Disorder, Cosima M Schmid, Anne Gregor, Anna Ruiz, et al.
Identifying Bio-Behavioural Signatures of Persistent Opioid Use Risk in Trauma Injury Patients: A Protocol for a Prospective Cohort Study, Joy M Schmitz, Jin Ho Yoon, Bruno Kluwe-Schiavon, et al.
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO), Kathryn H Schmitz, Justin C Brown, Melinda L Irwin, et al.
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D, Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, et al.